May deal activity was similar to April volume and values (after adjusting for USD 11 bn Sun Pharma deal), indicating sustained momentum and resilience in deal market in the backdrop of continued global uncertainty. Average deal values have seen an uptick as there is an increased strategic intent in M&A among domestic large corporates (14 deals above USD 50 million), alongside a strong appetite for high-value fund raises from private equity (14 deals above 50 million). Overall, the deal market continues to show consistency in participation as capital remains focused on strategic relevance and high value opportunities.
Shanthi Vijetha
Partner, Deals Lifecycle, Grant Thornton Bharat